Karen L. Mohlke

Has grant

Professor

University of North Carolina at Chapel Hill
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

Determining the Genetic Basis of Hidradenitis Suppurativa

Open Date: 2024-08-22

Close Date: 2029-07-31

Grant: Close

Genetics of adipose cell-type expression and cardiometabolic traits

Open Date: 2022-05-01

Close Date: 2026-04-30

Grant: Open

Regulatory Genomics of Ozone Air Pollution Response in Vitro and In Vivo

Open Date: 2022-04-18

Close Date: 2027-02-28

Grant: Close

Systematic in vivo characterization of disease-associated regulatory variants

Open Date: 2021-09-01

Close Date: 2026-05-31

Grant: Close

Bridging the gap between type 2 diabetes GWAS and therapeutic targets

Open Date: 2020-08-20

Close Date: 2025-06-30

Articles (9)

Fibro-adipogenic progenitors (FAPs) in skeletal muscle have been implicated in type 2 diabetes (T2D) risk, yet their heterogeneity and context-dependent regulation remain poorly understood. Here, we establish induced pluripotent stem cell (iPSC)-derived FAPs as a faithful model of primary FAPs by leveraging a unique resource: iPSC lines and skeletal muscle biopsies obtained from the same 30 individuals. Donor-matched comparisons reveal that iPSC-FAPs recapitulate the transcriptome, epigenome, and subtype composition of muscle tissue FAPs. Using single-nucleus multiomics, we show that high-insulin exposure drives iPSC-FAPs toward an adipogenic fate - and that this adipogenic subtype is enriched for T2D GWAS signals, an enrichment undetectable under baseline conditions. We map the T2D-associated rs3814707 non-coding signal to LTBP3 , a gene that influences FAP adipogenic differentiation. These findings reveal how disease-relevant regulatory mechanisms can be masked in unstimulated cells and establish iPSC-FAPs as a powerful platform for dissecting the state-dependent biology of complex metabolic disease.

Year:

2026

Cell type-specific chromatin accessibility QTL (caQTL) mapping is a promising approach to understand genetic control of chromatin landscapes and identify regulatory mechanisms underlying GWAS associations. However, current caQTL studies lack resolution and do not distinguish nucleosome-free regions (NFR) from positioned nucleosomes. Here, we leverage statistical modeling of fragment position and length to decompose ATAC-seq profiles into NFRs and phased nucleosomes. With single nucleus (sn)ATAC-seq from 281 human muscle biopsies, we map cell type-specific genetic effects on NFRs (76,027 nfrQTLs) and nucleosome occupancy (24,623 nucQTLs) across skeletal muscle cell types. Colocalization and causal inference between nucQTLs and nearby nfrQTLs and show that nfrQTLs are substantially more likely to causally influence nucQTLs and phase adjacent nucleosomes, indicating a causal relationship in shaping chromatin profiles. Hundreds of nfrQTLs colocalize with GWAS signals for muscle-related traits, including grip strength, atrial fibrillation, and fasting insulin, and the majority of colocalizing signals mapped to credible sets overlapping the corresponding nfrPeak. This approach adds mechanistic insights for how variants underlying caQTLs and GWAS signals exert their cis regulatory effects by initially modifying NFR accessibility and subsequently shaping broader chromatin landscapes, nucleosome positioning, gene expression, and ultimately higher-level traits and disease.

Year:

2025

The liver is a central regulator of cardiometabolic physiology, coordinating processes such as lipid and glucose metabolism, protein synthesis, and detoxification. Genome-wide association studies (GWAS) have identified hundreds of genetic variants associated with cardiometabolic traits, yet their molecular mechanisms in liver cell types remain unclear. Using multiome single-nucleus RNA and ATAC sequencing on liver samples from 39 individuals, we profiled gene expression and chromatin accessibility in 68,398 nuclei across six primary liver cell types. We identified 306,706 accessible chromatin regions, including 70,884 regions undetected in bulk tissue analyses and that predominantly represent less abundant cell types. To identify genetic effects on gene regulation in liver cell types, we mapped quantitative trait loci (QTLs) and detected 1,885 chromatin accessibility QTLs (caQTLs) and 67 expression QTLs (eQTLs). We integrated cell-type QTLs with GWAS signals and revealed cell types, genes, and chromatin regulatory elements involved in cardiometabolic traits, such as liver enzyme and cholesterol levels. Non-hepatocyte cell-type QTL analyses exposed previously obscured mechanisms, such as an eQTL for ADAMTS12 in liver sinusoidal endothelial cells potentially involved in liver fibrosis, demonstrating that single-nucleus approaches can capture regulatory events missed in bulk analyses. Furthermore, we predicted cell type of action for bulk liver caQTLs colocalized with GWAS signals, enhancing mechanistic insights for complex trait associations. Our findings provide a high-resolution map of the hepatic regulatory landscape and advance the understanding of cellular contexts and molecular mechanisms underlying cardiometabolic traits.

Year:

2025

Expression quantitative trait locus (eQTL) studies in human cohorts typically detect at least one regulatory signal per gene, and have been proposed as a way to explain mechanisms of genetic liability for other traits, as discovered in genome-wide association studies (GWAS). In particular, eQTL signals may colocalize with GWAS signals, suggesting gene expression as a possible mediator. However, recent studies have noted colocalization occurs infrequently, even when expression is measured in biologically relevant tissues. Most eQTL studies to date include only hundreds of individuals, and are underpowered to discover distal regulatory signals explaining smaller fractions of gene expression variance. We integrate evidence from recent eQTL studies and demonstrate that limited statistical power due to sample size skews the detection of eQTL signals identified at various signal strengths. We estimate that a sample size of 500 detects <0.1 to 60% of eQTL for a range of signal strengths and that a sample size of 2,000 would detect 36.8% of all eQTL. We show that eQTL signals that can only be discovered in larger studies exhibit characteristics more similar to those of GWAS signals, including greater distance to the regulated gene and higher probability of loss intolerance. Finally, using results from recent eQTL studies and meta-analyses, we observe a large increase in detected colocalizations with GWAS signals compared to previous studies. These findings caution against overinterpreting the absence of colocalization in underpowered studies and provide guidance for designing future eQTL experiments, to improve power and complement perturbation-based approaches in characterizing gene-trait mechanisms.

Year:

2025

Chromatin accessibility quantitative trait locus (caQTL) studies have identified regulatory elements that underlie genetic effects on gene expression and metabolic traits. However, caQTL discovery has been limited by small sample sizes. Here, we map caQTLs in liver tissue from 138 human donors and identify caQTLs for 35,361 regulatory elements, including population-specific caQTLs driven by differences in allele frequency across populations. We identify 2126 genetic signals associated with multiple, presumably coordinately regulated elements. Coordinately regulated elements link distal elements to target genes and are more likely to be associated with gene expression compared with single-element caQTLs. We predict driver and response elements at coordinated loci and find that driver elements are enriched for transcription factor binding sites of key liver regulators. We identify colocalized caQTLs at 667 genome-wide association (GWAS) signals for metabolic and liver traits, and annotate these loci with predicted target genes and disrupted transcription factor binding sites. CaQTLs identify threefold more GWAS colocalizations than liver expression QTLs (eQTLs) in a larger sample size, suggesting that caQTLs can detect mechanisms missed by eQTLs. At a GWAS signal colocalized with a caQTL and an eQTL for TENM2 , we validated regulatory activity for a variant within a predicted driver element that is coordinately regulated with 39 other elements. At another locus, we validate a predicted enhancer of RALGPS2 using CRISPR interference and demonstrate allelic effects on transcription for a haplotype within this enhancer. These results demonstrate the power of caQTLs to characterize regulatory mechanisms at GWAS loci.

Year:

2025

Measures from affinity-proteomics platforms often correlate poorly, challenging interpretation of protein associations with genetic variants (pQTL) and phenotypes. Here, we examined 2,157 proteins measured on both SomaScan 7k and Olink Explore 3072 across 1,930 participants with genetic similarity to European, African, East Asian, and Admixed American ancestry references. Inter-platform correlation coefficients for these 2,157 proteins followed a bimodal distribution (median r=0.30). Protein measures were associated with variants (pQTLs), and one-third of the pQTL signals were driven by protein-altering variants (PAVs). We highlight 80 proteins that correlate differently across ancestry groups likely due to differing PAV frequencies by ancestry. Furthermore, adjustment for PAVs with opposite directions of effect by platform improved inter-platform protein measure correlation and resulted in more concordant genetic and phenotypic associations. Hence, PAVs need to be accounted for across ancestries to facilitate platform-concordant and accurate protein measurement.

Year:

2025

Genome-wide association studies (GWAS) have identified numerous body mass index (BMI) loci. However, most underlying mechanisms from risk locus to BMI remain unknown. Leveraging omics data through integrative analyses could provide more comprehensive views of biological pathways on BMI. We analyzed genotype and blood gene expression data in up to 5,619 samples from the Framingham Heart Study (FHS). Using 3,992 single nucleotide polymorphisms (SNPs) at 97 BMI loci and 20,692 transcripts within 1 Mb, we performed separate association analyses of transcript with BMI and SNP with transcript (P BMI and P SNP , respectively) and then a correlated meta-analysis between the full summary data sets (P META ). We identified transcripts that met Bonferroni-corrected significance for each omic, were more significant in the correlated meta-analysis than each omic, and were at least nominally associated with BMI in FHS data. Among 308 significant SNP-transcript-BMI associations, we identified seven genes ( NT5C2 , GSTM3 , SNAPC3 , SPNS1 , TMEM245 , YPEL3 , and ZNF646 ) in five association regions. Using an independent sample of blood gene expression data, we validated results for SNAPC3 and YPEL3 . We tested for generalization of these associations in hypothalamus, nucleus accumbens, and liver and observed significant (P META <0.05 & P META <P SNP & P META <P BMI ) results for YPEL3 in nucleus accumbens and NT5C2 , SNAPC3 , TMEM245 , YPEL3 , and ZNF646 in liver. The identified genes help link the genetic variation at obesity risk loci to biological mechanisms and health outcomes, thus translating GWAS findings to function.

Year:

2024

Osteoarthritis (OA) poses a significant healthcare burden with limited treatment options. While genome-wide association studies (GWAS) have identified over 100 OA-associated loci, translating these findings into therapeutic targets remains challenging. Integrating expression quantitative trait loci (eQTL), 3D chromatin structure, and other genomic approaches with OA GWAS data offers a promising approach to elucidate disease mechanisms; however, comprehensive eQTL maps in OA-relevant tissues and conditions remain scarce. We mapped gene expression, chromatin accessibility, and 3D chromatin structure in primary human articular chondrocytes in both resting and OA-mimicking conditions. We identified thousands of differentially expressed genes, including those associated with differences in sex and age. RNA-seq in chondrocytes from 101 donors across two conditions uncovered 3782 unique eGenes, including 420 that exhibited strong and significant condition-specific effects. Colocalization with OA GWAS signals revealed 13 putative OA risk genes, 10 of which have not been previously identified. Chromatin accessibility and 3D chromatin structure provided insights into the mechanisms and conditional specificity of these variants. Our findings shed light on OA pathogenesis and highlight potential targets for therapeutic development. Highlights ∘ Comprehensive analysis of sex- and age-related global gene expression in human chondrocytes revealed differences that correlate with osteoarthritis ∘ First response eQTLs in chondrocytes treated with an OA-related stimulus ∘ Deeply sequenced Hi-C in resting and activated chondrocytes helps connect OA risk variants to their putative causal genes ∘ Colocalization analysis reveals 13 (including 10 novel) putative OA risk genes

Year:

2024

Understanding differences in adipose gene expression between individuals with different levels of clinical traits may reveal the genes and mechanisms leading to cardiometabolic diseases. However, adipose is a heterogeneous tissue. To account for cell-type heterogeneity, we estimated cell-type proportions in 859 subcutaneous adipose tissue samples with bulk RNA sequencing (RNA-seq) using a reference single-nuclear RNA-seq data set. Cell-type proportions were associated with cardiometabolic traits; for example, higher macrophage and adipocyte proportions were associated with higher and lower BMI, respectively. We evaluated cell-type proportions and BMI as covariates in tests of association between >25,000 gene expression levels and 22 cardiometabolic traits. For >95% of genes, the optimal, or best-fit, models included BMI as a covariate, and for 79% of associations, the optimal models also included cell type. After adjusting for the optimal covariates, we identified 2,664 significant associations (P ≤ 2e−6) for 1,252 genes and 14 traits. Among genes proposed to affect cardiometabolic traits based on colocalized genome-wide association study and adipose expression quantitative trait locus signals, 25 showed a corresponding association between trait and gene expression levels. Overall, these results suggest the importance of modeling cell-type proportion when identifying gene expression associations with cardiometabolic traits. Article Highlights

Year:

2023

Collaborators (31)

Josyf Mychaleckyj

Professor

University of Virginia

UNITED STATES
View details

Laura J Scott

University of Michigan

UNITED STATES
View details

Andre Monteiro da Rocha

University of Michigan

UNITED STATES
View details

Joseph McCormick

James H. Steele Professor

-

UNITED STATES
View details

Bing Yu

Professor

The University of Texas Health Science Center at Houston

UNITED STATES
View details

Honghuang Lin

Professor

UMass Medical School

UNITED STATES
View details

Peter Ganz

University of California, San Francisco

UNITED STATES
View details

Laura Raffield

Assistant Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Stephanie Bielas

University of Michigan

UNITED STATES
View details

Mary Rooney

Assistant Research Professor

Johns Hopkins University

UNITED STATES
View details

Peifeng Ruan

Assistant Professor

University of Texas Southwestern Medical Center

UNITED STATES
View details

Ching-Ti Liu

Boston University

UNITED STATES
View details

Josef Coresh

Professor

Johns Hopkins University

UNITED STATES
View details

Timo Lakka

Professor of Medical Physiology

University of Eastern Finland

FINLAND
View details

Heikki Koistinen

University of Helsinki

FINLAND
View details

Yi-Hui Zhou

Associate Professor

North Carolina State University

UNITED STATES
View details

Amil Shah

Professor of Medicine, Director of Population Sciences

University of Texas Southwestern Medical Center

UNITED STATES
View details

Terry Furey

Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Michael Love

Associate Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Robert Gerszten

Chief of Cardiology

Beth Israel Deaconess Medical Center

UNITED STATES
View details

Kari North

Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Quan Sun

Research Assistant Professor

University of Pennsylvania

UNITED STATES
View details

Mariaelisa Graff

Assistant Professor

University of North Carolina

UNITED STATES
View details

Brian O. Diekman

Assistant Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Douglas H Phanstiel

Assistant Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Anne Justice

Associate Professor

Geisinger Health

UNITED STATES
View details

Michael Boehnke

Professor

University of Michigan

UNITED STATES
View details

Lekki Wood

Assistant Professor

Baylor College of Medicine

UNITED STATES
View details

Markku Laakso

University of Eastern Finland

FINLAND
View details

Yun Li

Professor

University of North Carolina

UNITED STATES
View details

Richard Loeser

Professor

University of North Carolina

UNITED STATES
View details